| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-09 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-07 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |